The "top 100' drugs and classes in England: an updated "starter formulary' for trainee prescribers

被引:47
作者
Audi, Selma [1 ]
Burrage, Daniel R. [1 ,3 ]
Lonsdale, Dagan O. [1 ,3 ]
Pontefract, Sarah [4 ,5 ]
Coleman, Jamie J. [4 ,5 ]
Hitchings, Andrew W. [2 ,3 ]
Baker, Emma H. [1 ,3 ]
机构
[1] St Georges Univ London, Inst Infect & Immun, Clin Pharmacol, London, England
[2] St Georges Univ London, Inst Med & Biomed Educ, Clin Pharmacol, London, England
[3] St Georges Univ Hosp NHS Fdn Trust, London, England
[4] Univ Birmingham, Inst Clin Sci, Birmingham, W Midlands, England
[5] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
基金
美国国家卫生研究院;
关键词
general medicine; medical education; pharmacoepidemiology;
D O I
10.1111/bcp.13709
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AimsPrescribing is a complex skill required of doctors and, increasingly, other healthcare professionals. Use of a personal formulary can help to develop this skill. In 2006-9, we developed a core list of the 100 most commonly prescribed drugs. Our aim in the present study was to update this starter formulary' to ensure its continued relevance for prescriber training. MethodsWe analysed large contemporary primary and secondary care datasets to identify the most frequently prescribed medicinal products. Items were classified into natural groups, broadly following their British National Formulary classification. The resulting drug groups were included in the core list if they comprised 0.1% prescriptions in both settings or 0.2-0.3% prescriptions in one setting. Drugs from emergency guidelines that did not qualify by prescribing frequency completed the list. ResultsOver 1 billion primary care items and approximately 1.8 million secondary care prescriptions were analysed. The updated list comprises 81 drug groups commonly prescribed in both settings; six from primary care; seven from secondary care; and six from emergency guidelines. Eighty-eight per cent of the formulary was unchanged. Notable changes include entry of newer anti-epileptics and dipeptidyl peptidase-4 inhibitors and exit of phenytoin and thiazolidinediones. ConclusionsThe relative stability of the core drug list over 9 years and the current update ensure that learning based on this list remains relevant to practice. Trainee prescribers may be encouraged to use this starter formulary' to develop a sound basis of prescribing knowledge and skills that they can subsequently apply more widely.
引用
收藏
页码:2562 / 2571
页数:10
相关论文
共 17 条
[1]  
[Anonymous], 2017, GUID MAN COMM MED EM
[2]  
[Anonymous], 2015, TYPE 2 DIABETES ADUL
[3]  
[Anonymous], PRESCR COST AN ENGL
[4]  
Baker E, 2016, P BR PHARM SOC, V16
[5]   Development of a core drug list towards improving prescribing education and reducing errors in the UK [J].
Baker, Emma ;
Roberts, Adele Pryce ;
Wilde, Kirsty ;
Walton, Hannah ;
Suri, Sati ;
Rull, Gurvinder ;
Webb, Andrew .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (02) :190-198
[6]   The Established Status Epilepticus Trial 2013 [J].
Bleck, Thomas ;
Cock, Hannah ;
Chamberlain, James ;
Cloyd, James ;
Connor, Jason ;
Elm, Jordan ;
Fountain, Nathan ;
Jones, Elizabeth ;
Lowenstein, Daniel ;
Shinnar, Shlomo ;
Silbergleit, Robert ;
Treiman, David ;
Trinka, Eugen ;
Kapur, Jaideep .
EPILEPSIA, 2013, 54 :89-92
[7]  
British Medical Association, 2017, PRESCR SAF ASS
[8]  
British National Formulary, BRIT NATL FORMULARY
[9]   Should medical students learn to develop a personal formulary? [J].
De Vries, T. P. G. M. ;
Daniels, J. M. A. ;
Mulder, C. W. ;
Groot, O. A. ;
Wewerinke, L. ;
Barnes, K. I. ;
Bakathir, H. A. ;
Hassan, N. A. G. M. ;
Van Bortel, L. ;
Kriska, M. ;
Santoso, B. ;
Sanz, E. J. ;
Thomas, M. ;
Ziganshina, L. E. ;
Bezemer, P. D. ;
Van Kan, C. ;
Richir, M. C. ;
Hogerzeil, H. V. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (06) :641-646
[10]  
General Medical Council, 2015, 0UTC GRAD